LCS
FLGT icon

Levin Capital Strategies’s Fulgent Genetics FLGT Stock Holding History

Levin Capital Strategies’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
105,542
+62,308
+144% +$1.06M 0.15% 105
2026
Q1 		$687K Buy
+43,234
New +$938K 0.05% 133

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Levin Capital Strategies's FLGT Position: Q2 2026 in Review

Levin Capital Strategies increased its Fulgent Genetics (FLGT) stake by 144% in Q2 2026, buying an estimated $1.06M and bringing the position to 105,542 shares worth $2.17M. The position accounts for 0.15% of the portfolio, ranked #105.

Levin Capital Strategies first reported a position in FLGT in Q1 2026 and has held it in 2 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Levin Capital Strategies held 105,542 shares of Fulgent Genetics worth $2.17M as of Q2 2026.
  • Levin Capital Strategies bought 62,308 Fulgent Genetics shares in Q2 2026, an estimated $1.06M.
  • Fulgent Genetics made up 0.15% of Levin Capital Strategies's portfolio in Q2 2026, its #105 holding.
  • Levin Capital Strategies first reported a position in Fulgent Genetics in Q1 2026 and has held it in 2 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.